In addition, upregulation of FBXO22 mRNA was confirmed by quantitative real-time PCR (qRT-PCR) in cancer tissues of a cohort of 37 colorectal cancer patients compared to adjacent normal tissues (Fig. 7c, Supplementary Data 2). This evidence concerns the gene FBXO22 and colorectal cancer.